SDGR - NASDAQ

Schrödinger, Inc.

SDGR·NASDAQ

$15.97

+6.9%

HealthcareMedical - Healthcare Information Services

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.19B

EPS-1.4100

P/E Ratio-11.33

Earnings Date08/05/2026

726.16M

Assets

-12%

3Y+5.0%

5Y-3.0%

10Y+1152.0%

362.11M

Total Liabilities

-10%

3Y+50.0%

5Y+196.0%

10Y+250.0%

364.05M

Total Equity

-14%

3Y-19.0%

5Y-42.0%

10Y-903.0%

Schrödinger, Inc. Funding & Solvency Profile

SDGR · NASDAQ

Current Assets

Cash & Cash Equivalents230.52M

Net Receivables83.04M

Inventory0.00

Other Current Assets40.76M

Total Current Assets519 M

Non-Current Assets

Property, Plant & Equipment122.19M

Goodwill & Intangible Assets4.79M

Long-Term Investments73.65M

Other Non-Current Assets6.26M

Total Non-Current Assets202 M

Total Assets

726.16M

Financial Health Analysis

Current Ratio

2.75x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.99x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

330 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

72% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Schrödinger, Inc. Balance Sheet

SDGR • NASDAQ

Schrödinger, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	230.5M	147.3M	155.3M	90.5M	120.3M	202.3M	26M	77.7M	10M
Short-Term Investments	164.9M	204.8M	307.7M	360.6M	456.2M	440.4M	59.8M	6.4M	26.4M
Cash & Short-Term Investments	395.5M	352.1M	463M	451.1M	576.5M	642.7M	85.8M	84.1M	36.3M
Net Receivables	83M	255.3M	89.1M	69.1M	40.6M	35.4M	25.7M	18M	9.8M
Accounts Receivables	83M	235.7M	66M	56M	31.7M	31.4M	18.7M	13.6M	9.4M
Other Receivables	0.0	19.6M	23.1M	13.1M	8.8M	4M	7.1M	4.4M	385K
Prepaids	0.0	12.2M	9.9M	8.6M	5M	4.4M	6.5M	2.6M	2M
Other Current Assets	40.8M	15.3M	5.8M	5.2M	3M	500K	500K	0.0	0.0
Total Current Assets	519.3M	635M	567.8M	534M	625.1M	683M	118.5M	104.7M	48.1M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	122.2M	136.1M	141.1M	120.2M	85.4M	15.3M	19M	8M	5.4M
Goodwill	4.8M	4.8M	4.8M	4.8M	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	0.0	0.0	587K	0.0	0.0	0.0	15K	52K
Goodwill & Intangible Assets	4.8M	4.8M	4.8M	5.4M	0.0	0.0	0.0	15K	52K
Long-Term Investments	73.6M	43.2M	83.3M	25.7M	43.2M	45.7M	15.4M	5.4M	2.6M
Other Non-Current Assets	6.3M	4.2M	6M	3.3M	2.9M	2.4M	2.3M	2.6M	1.9M
Total Non-Current Assets	206.9M	188.2M	235.2M	154.6M	131.4M	63.3M	36.7M	16M	10M
Total Assets	726.2M	823.2M	803M	688.6M	756.5M	746.3M	155.3M	120.7M	58M
LIABILITIES
CURRENT LIABILITIES
Total Payables	11.5M	10.7M	16.8M	9.5M	8.1M	8.4M	3.5M	2.8M	1.6M
Accounts Payable	11.5M	10.7M	16.8M	9.5M	8.1M	8.4M	3.5M	2.8M	1.6M
Accrued Expenses	0.0	52.4M	43.8M	30.4M	25.7M	14.9M	10.9M	6.6M	2.8M
Short Term Debt	16.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations (Current)	0.0	16.8M	16.9M	11M	2M	4.5M	5.6M	0.0	0.0
Deferred Revenue	112.9M	111.9M	56.2M	57.9M	55.4M	45.4M	25.1M	17.6M	11M
Other Current Liabilities	48.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4M
Total Current Liabilities	189.1M	191.7M	133.7M	108.8M	91.2M	73.2M	45M	27M	17.8M
NON-CURRENT LIABILITIES
Deferred Revenue (Non-Current)	78.9M	108.8M	9M	25.6M	30.1M	41.2M	2.2M	3.1M	2.8M
Other Non-Current Liabilities	1.3M	146K	667K	800K	300K	654K	192.5M	162.2M	82.8M
Total Non-Current Liabilities	173M	210M	120.7M	131.9M	108.2M	49M	203.6M	165.3M	85.6M
Capital Lease Obligations	92.8M	117.8M	127.9M	116.5M	79.9M	11.8M	14.5M	0.0	0.0
Total Liabilities	362.1M	401.8M	254.4M	240.7M	199.4M	122.2M	248.6M	192.3M	103.4M
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-8.5M	-6.4M
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.7M	82.3M
Common Stock	645K	729K	722K	714K	710K	699K	61K	59K	55K
Additional Paid-In Capital	992M	946M	886M	828.7M	787M	752.6M	11.7M	8.5M	6.4M
Retained Earnings	-628.8M	-525.5M	-338.4M	-379.1M	-230M	-129.6M	-105.1M	-80.5M	-52.1M
Accumulated Other Comprehensive Income/Loss	107K	220K	281K	-2.4M	-651K	317K	16K	-9K	-27K
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-152.8M	-75.6M
Total Stockholders' Equity	364.1M	421.4M	548.6M	447.9M	557.1M	624M	-93.4M	-71.6M	-45.4M
Total Equity	364.1M	421.4M	548.6M	447.9M	557.1M	624M	-93.3M	-71.6M	-45.4M
Minority Interest	0.0	0.0	0.0	11K	14K	4K	41K	0.0	0.0
SUMMARY
Total Liabilities & Equity	726.2M	823.2M	803M	688.6M	756.5M	746.3M	155.3M	120.7M	58M
Total Investments	238.6M	248M	390.9M	386.3M	499.4M	486.1M	75.2M	11.8M	29M
Total Debt	109.2M	117.8M	127.9M	116.5M	79.9M	11.8M	14.5M	0.0	0.0
Net Debt	-121.3M	-29.5M	-27.4M	26M	-40.4M	-190.5M	-11.5M	-77.7M	-10M
Shares Outstanding	73,664,656	73,664,656	73,664,656	73,664,656	73,664,656	73,664,656	73,664,656	73,664,656	73,664,656

SEC Filings

SDGR - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 20, 2026	May 18, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 05, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 28, 2026	April 28, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 12, 2026	March 06, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 25, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 25, 2026	February 25, 2026	2026	View Filing
8-K 8-K 2025 N/A	November 05, 2025	November 05, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 05, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	September 08, 2025	September 05, 2025	2025	View Filing

Showing 1 to 10 of 88 filings

Related Guides

Blog Categories

Continue your SDGR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.